Suppliers / Bliss GVS Pharma

Bliss GVS Pharma

India 2 duplicate records merged Updated 9 July 2026

Bliss GVS Pharma is a finished-dose manufacturer based in India. It appears in 165 regulatory filings across 14 regulators, without an active US DMF or CEP on file. Its filings concentrate with ZAMRA (ZM), NAFDAC (NG) and TMDA (TZ). Its GMP standing is certified by CDSCO (India), TMDA (TZ) and FDA (GH), among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 17 March 2023 as VAI. Customs aggregates show $65.5M of exports covering 2,638 molecules to 56 destinations in 2025.

0
active US DMFs
0
valid CEPs
7
registered plants 2 with an FDA FEI number
165
filings across 14 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
1 of 1 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 17 March 2023 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Maharashtra, United Arab Emirates Not on file
Palghar, India 3007068506
Palghar, India 3008380269
ay stationvillage ranoli 391 350vadodara, India Not on file
vapivapi 396 195 valsad, India Not on file
valsad 396 125, India Not on file

1 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
ZAMRA (ZM) 51 None
NAFDAC (NG) 31 1
TMDA (TZ) 21 2
FDA (GH) 18 2
MINSA (CR) 11 None
DAV (Vietnam) 10 None
CDSCO (India) None 4
EMA None 1

Scale

Year Revenue Exports Destinations
2025 Not reported $65.5M 56
2024 Not reported $74.2M 52
2023 Not reported $69.0M 58
2022 Not reported $69.8M 53

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Bliss GVS Pharma

Does Bliss GVS Pharma hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Bliss GVS Pharma. It does have 165 filings with 14 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Bliss GVS Pharma FDA-registered?
2 sites operated by Bliss GVS Pharma carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Bliss GVS Pharma's last inspection go?
The most recent inspection on record closed on 17 March 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 1 inspection is on file.
Where does Bliss GVS Pharma manufacture?
7 registered sites are on record, in United Arab Emirates and India (Maharashtra, Palghar and Ay Stationvillage Ranoli 391 350vadodara among others). Every site is listed on this page with the register it came from.
Which regulators recognise Bliss GVS Pharma's GMP?
Current GMP certificates are on record from CDSCO (India), TMDA (TZ), FDA (GH), NAFDAC (NG) and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Bliss GVS Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 17 March 2023.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts